NEW YORK, July 23, 2020 (GLOBE NEWSWIRE) – Establishment Labs Holdings Inc. (Nasdaq: ESTA), a comparative block of women’s fitness generation, first in breast aesthetics and the retransmission market position, plans to announce its economic effects for the finalized quarter June 30, 2020 after the closing of the market position on Thursday, August 6, 2020 , and you could make a conference call at 5:30 p.m. ET that day to talk about those effects.
To connect to the conference call, call (877) 376-992five (USA). (629) 228-0732 (international) and use conference identity number 2649347. The call can also be made via a live phone or archived web stream on the “Investor Relations” website of the Establishment Labs website in www.establishmentlabs.com.
About Establishment Labs Establishment Labs Holdings Inc. (NASDAQ: ESTA) is a foreign fitness generation company for women, first in the aesthetics of the breast and market position of retransmission, design, development, production and market positioning of a state-of-the-art portfolio of implants filled with silicone gel, under the Motiva Implants brand®, the centerpiece of the MotivaImagine platform®. Motiva Implants® is produced at our two ISO1348five compliant production sites: 2016, FDA 21 CFR 820 under the MDSAP program, and lately they are on the market in more than 80 countries through exclusive suppliers or the company’s direct sales force. In March 2018, Establishment Labs obtained FDA approval for an Intellectual Device Waiver (IDE) and announced the Motiva Implant® clinical trial in the United States in April 2018. In addition to Motiva Implants®, Establishment Labs’ product and generation portfolio includes Divina 3-d simulation formula® and other products and services. Visit our website for more information: www.establishmentlabs.com